Psychedelic therapy

Psychedelic therapy has gained increasing attention in recent years. But what exactly is it, how does it work, and for whom could it be a real opportunity? Let's take a closer look at the topic!

What is psychedelic therapy?

Psychedelic therapy is an innovative form of treatment in which mind-altering substances - known as psychedelics - are used in a therapeutic setting to treat mental illness. Commonly used substances include

• Psilocybin (contained in "Magic Mushrooms")
• LSD (Lysergsäurediethylamid)
• MDMA (Methylenedioxy-N-methylamphetamin)
• Ketamin

These substances act on the central nervous system and can trigger deep emotional and cognitive processes. Psychedelic therapy is usually accompanied by specially trained therapists and takes place in a controlled environment to minimise the risk of unwanted side effects.

The therapeutic process utilises the altered consciousness to resolve deep-seated traumas, depression or fears. The focus is often on emotional insights and the experience of connectedness, which can support the healing process. In a way, psychedelics open doors in the consciousness that remain closed in normal everyday life.

The therapy is currently being intensively researched as it shows great potential, particularly in patients who do not respond to conventional treatments.

Psychedelic therapy in Germany

In Germany, the psychedelic therapy The use of psychedelic substances faces legal hurdles, as most psychedelic substances such as psilocybin and LSD fall under the German Narcotics Act (BtMG) and are therefore illegal. The therapeutic use of these substances is highly regulated and in most cases only possible in the context of clinical studies or under special conditions. One exception is Ketamin which is used in low doses as an authorised medication in the treatment of depression. This so-called Ketamintherapie is legal in Germany and is offered in specialised clinics.

In cities like München , Berlin and Frankfurt there are initial approaches to researching psychedelic therapies and offering them in certain settings, often in conjunction with university research. There are also more advanced approaches in Switzerland and the Netherlands that serve as an alternative for German patients. The legal situation in Germany could change in the next few years, as interest in psychedelic therapy and research results continue to grow.

Costs of psychedelic therapy in Germany

The Costs for psychedelic therapy in Germany depend mainly on the type of treatment. As most psychedelic substances such as psilocybin and LSD are illegal, it is currently almost exclusively the Ketamintherapie legally accessible. A session usually costs between 200 and 500 euros, depending on the practice and the intensity of treatment. As the therapy often requires several sessions, the total cost can easily amount to several thousand euros. Unfortunately, health insurance companies do not cover these costs in most cases, which means that patients have to finance the therapy themselves. This represents a considerable financial hurdle for many, as the treatments have to be carried out over longer periods of time in order to achieve lasting effects.

Psychedelic therapy training

The Training as a therapist for psychedelic therapy in Germany is still in its infancy and is strictly regulated due to the legal situation. In order to become a therapist in this field, an existing qualification as a Psychotherapeut , Doctor or Psychiater required. These professionals must then complete special further training in the use of psychedelics in a therapeutic context.

Especially with the Ketamintherapie there are already recognised training programmes in which doctors and therapists are trained to use this form of therapy safely. The training programmes include knowledge about dosage, dealing with possible side effects and psychotherapeutic support for patients during and after the sessions.

For substances such as psilocybin or MDMA, training is currently only possible as part of clinical studies or abroad, as these substances are not yet legal in Germany. The training focuses on the safe use of the substances, therapeutic support and the integration of the experiences gained into the patient's everyday life. However, with increasing research and potential legalisation, specific training paths could also emerge in Germany in the future.

Future developments and potential in Germany

• The future of psychedelic therapy :
  The prospects for psychedelic therapy in Germany are promising. Current research findings and social changes show the growing potential of this form of therapy. Studies worldwide show that substances such as psilocybin, MDMA and ketamine are effective in the treatment of depression, anxiety disorders and post-traumatic stress disorder (PTSD). Clinical trials are already underway in Germany to confirm the efficacy and safety of these approaches.

• Legalisierung :
  The legalisation of psychedelics for therapeutic purposes could become a reality in the next few years. Especially if research results continue to show positive developments and social pressure for new treatment options increases. Countries such as the USA and Canada are pioneers in the legalisation of MDMA and psilocybin, which could also influence the process in Germany.

• Social acceptance :
  Acceptance of alternative forms of therapy is increasing, particularly due to the growing openness towards mental health. The search for effective treatments for therapy-resistant illnesses is reinforcing this trend. Psychedelic therapies could gain in importance in Germany if they are supported by research findings and offered in a controlled setting. This could permanently change and diversify the psychotherapeutic landscape in Germany.